National Covid-19 Surveillance Physicians

Official Title

National Covid-Surveillance Physicians

Brief Summary

The investigators will analyze the presence of antibodies against SARS-COV2 in physicians working in emergency and intensive care medicine and in those who treat Covid 19 patients.

Status

Unknown status

Conditions

Antibody COVID-19

Interventions

Diagnostic Test: Antibody test (SARS-CoV2)

Antibody test

Eligibility Criteria

Inclusion Criteria:

- Qualified as physician

Exclusion Criteria:

- none

Eligibility Gender

All

Eligibility Age

Minimum: 18 Years ~ Maximum: 99 Years

Countries

Germany

Locations

University Hospital Duesseldorf, Dept. of Anesthesiology
Duesseldorf, Germany

Investigator: Detlef Kindgen-Milles, Prof.
Contact: 004902118107047
kindgen-milles@med.uni-duesseldorf.de

NCT Number

NCT04459312

MeSH Terms

COVID-19

Antibodies

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Dr. Wetzchewald

National Covid-19 Surveillance Physicians

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA